Showing results (11-20 of 50) with videos related to
Sort By:
Pageof 5
Journal of Medical Case Reports|March 23, 2011
Gastrointestinal relapse of multiple myeloma and sustained response to lenalidomide: a case reportPatrick R Benusiglio, Thomas A McKee, Xavier Montet, et al.European Journal of Human Genetics : EJHG|March 18, 2025
Pathogenic germline variants in patients with early-onset colorectal cancer according to phenotypeAntoine Dardenne, Marion Dhooge, Noémie Basset, et al.European Journal of Medical Genetics|August 23, 2021
Cancer predisposition and germline CTNNA1 variantsSilvana Lobo, Patrick R Benusiglio, Florence Coulet, et al.Journal of Medical Genetics|November 20, 2025
Expert endoscopic surveillance in <i>CDH1</i> pathogenic variant carriers seems safe, even after positive (pT1a) biopsiesPatrick R Benusiglio, Romain Leenhardt, Caroline Duros, et al.Familial Cancer|September 15, 2016
Hereditary breast and ovarian cancer: successful systematic implementation of a group approach to genetic counsellingPatrick R Benusiglio, Marina Di Maria, Leila Dorling, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 8, 2018
Pattern multiplicity and fumarate hydratase (FH)/S-(2-succino)-cysteine (2SC) staining but not eosinophilic nucleoli with perinucleolar halos differentiate hereditary leiomyomatosis and renal cell carcinoma-associated renal cell carcinomas from kidney tumors without FH gene alterationMarie Muller, Marine Guillaud-Bataille, Julia Salleron, et al.The Breast Journal|November 11, 2018
Low risk of invasive lobular carcinoma of the breast in carriers of BRCA1 (hereditary breast and ovarian cancer) and TP53 (Li-Fraumeni syndrome) germline mutationsYoan Ditchi, Chloé Broudin, Yolla El Dakdouki, et al.BMC Cancer|July 21, 2005
Common variation in EMSY and risk of breast and ovarian cancer: a case-control study using HapMap tagging SNPsPatrick R Benusiglio, Fabienne Lesueur, Craig Luccarini, et al.Lung Cancer (Amsterdam, Netherlands)|September 26, 2022
Characterization of lung cancers in patients with BRCA germline variants: A multicenter seriesMateo Sanchis-Borja, Vincent Fallet, Elisabeth Fabre, et al.Breast Cancer Research : BCR|March 4, 2005
Common ERBB2 polymorphisms and risk of breast cancer in a white British population: a case-control studyPatrick R Benusiglio, Fabienne Lesueur, Craig Luccarini, et al.Pageof 5